General thoracic surgery

Journal of the American College of Surgeons

Volumn 186, Issue 2, 1998, Pages 162-172

  Faber, L Penfield ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; ESOPHAGUS SURGERY; GENERAL SURGERY; HOSPITAL COST; HUMAN; LUNG CANCER; LUNG METASTASIS; LUNG SURGERY; LUNG TRANSPLANTATION; LUNG VOLUME; MESOTHELIOMA; PATIENT CARE; PRIORITY JOURNAL; REVIEW; THORAX SURGERY;

EID: 0031938288     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00008-8     Document Type: Article

References (62)

1. Orringer MB. What shall we call ourselves? The time for standardization. Ann Thorac Surg 1997;64:596-598.
2. Comprehensive Thoracic Surgery Curriculum. A program for study and clinical activity during thoracic surgery residency. Thoracic Surgery Directors Association, 1994.
3. Wright CD, Wain JC, Grillo HC, et al. Pulmonary lobectomy patient care pathway: a model to control cost and maintain quality. Ann Thorac Surg 1997;64:299-302.
4. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
5. Drings P, Bulzebruck H, and Vogt-Moykopf I. Prognostic impact of the new 5th edition of the TNM classification for lung cancer (1997). Lung Cancer 1997;18(suppl 1):215.
6. Mountain CF, and Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723.
7. Kutlu CA, Pastorino U, Maisey M, et al. Selective use of PET scan in the preoperative staging of lung cancer. Lung Cancer 1997; 18(suppl 1):96.
8. Vansteenkiste S, Stroobants S, DeLeyn P, et al. Detection of N2-disease in potentially operable non-small cell lung cancer with FDG-PET scan: a prospective study. Lung Cancer 1997;18(suppl 1):215.
9. Scott WJ, Gobar LS, Terry JD, et al. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996;111:642-648.
10. Martini N, Kris MG, Flehinger BJ, et al. Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993;55: 1365-1374.
11. Burkes RJ, Ginsberg RJ, Shepherd FA, et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 1992;10:580-586.
12. Bonomi P, and Faber LP. Neoadjuvant chemoradiation therapy in non-small-cell lung cancer: the Rush University experience. Lung Cancer 1993;9:383-390.
13. Albain KS, Rusch VW, Crosley JJ, et al. Concurrent cisplatin etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995;13:1880-1892.
14. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994;330:153-158.
15. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994;86:673-680.
16. Stewart LA, and Pignon JP. Chemotherapy in non-small-cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995;311:899-909.
17. Takizawa T, Terashima M, Koike T, et al. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg 1997;113:248-252.
18. Oda M, Murakami S, Hayashi Y, et al. The role of mediastinal lymph node dissection for clinical stage I non-small cell lung cancer. Lung Cancer 1997;18(suppl 1):97.
19. Urschel JD. Surgical treatment of peripheral small cell lung cancer. In: Kohman LJ, ed. Chest Surgery Clinics of North America. Small Cell Carcinoma. Philadelphia: WB Saunders; 1997:95-103.
20. Shepherd FA. Surgical management of small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, et al, eds. Lung Cancer. Principles and Practice. Philadelphia: Lippincott-Raven; 1996:899-913.
21. Albain KS. Small-cell-lung cancer: principles of management and role of surgical resection. General Thoracic Surgery Postgraduate Course 1997;8:29-30.
22. Crawford JO, O'Rourke M, Schiller JH, et al. Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. J Clin Oncol 1996;14:2774-2784.
23. Bonomi P, Kim K, Chang A, et al. Phase III trial comparing etoposide (E) cisplatin (C) versus Taxol (T) with cisplatin-G-CSP (G) versus Taxol-cisplatin in advanced non-small-cell lung cancer, an Eastern Cooperative Group (ECOG) trial. Proc Annu Meet Am Soc Clin Oncol 1996;15:A1145.
24. Faber LP, Bonomi P, Sharma M. Pulmonary complications following preoperative radiation therapy and simultaneous Taxol containing chemotherapy in stage III non-small cell lung cancer (NSCLC). Lung Cancer 1997;18(suppl 1):100.
25. The International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995;108:1122-1128.
26. Sugarbaker DJ, Garcia JP, Richards WG, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg 1996;224:288-294.
27. Smythe WR, Hwang HC, Amin KM, et al. Successful treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex-thymidine kinase gene. Ann Surg 1995;222: 78-86.
28. Kaiser LR, and Albelda SM. Gene transfer and thoracic surgery: more to come. Ann Thorac Surg 1997;63:1527-1528.
29. Cooper JD, Patterson GA, Sundaresan RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996;112: 1319-1330.
30. McKenna RJ Jr, Brenner M, Fischel RJ, et al. Should lung volume reduction for emphysema be unilateral or bilateral? J Thorac Cardiovasc Surg 1996;112:1331-1339.
31. Argenziano M, Thomashow B, Jellen PA, et al. Functional comparison of unilateral versus bilateral lung volume reduction surgery. Ann Thorac Surg 1997;64:321-327.
32. Wisser W, Tschernko E, Senbaklavaci O, et al. Functional improvement after volume reduction: sternotomy versus videoendoscopic approach. Ann Thorac Surg 1997;63:822-828.
33. Kotloff RM, Tino G, Bavaria JE, et al. Bilateral lung volume reduction surgery for advanced emphysema: a comparison of median sternotomy and thoracoscopic approaches. Chest 1996;110: 1399-1406.
34. Mack MJ, Scrubbs GR, Kelly KM, et al. Video-assisted thoracic surgery: has technology found its place? Ann Thorac Surg 1997;64:211-215.
35. Lewis RJ, Caccavale RJ, Sisler GE, et al. One hundred video-assisted thoracic surgical simultaneous stapled lobectomies without rib spreading. Ann Thorac Surg 1997;63:1415-1422.
36. Kirby TJ. Invited commentary. Lewis et al. VATS simultaneously stapled lobectomy. Ann Thorac Surg 1997;63:1421-1422.
37. Heniford BT, Carrillo EH, Spain DA, et al. The role of thoracoscopy in the management of retained thoracic collections after trauma. Ann Thorac Surg 1997;63:940-943.
38. Mack MJ, Landreneau RJ, Yim AP, et al. Results of video-assisted thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 1996;112:1352-1360.
39. Akaishi T, Kaneda I, Higuchi N, et al. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg 1996;112:1533-1541.
40. The International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
41. Robert JH, Ambrogi V, Mermillod B, et al. Factors influencing long-term survival after lung metastasectomy. Ann Thorac Surg 1997;63:777-784.
42. Abolhoda A, Brooks A, Nawata S, et al. Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases. Ann Thorac Surg 1997;64:181-184.
43. Sundaresan RS, Shiraishi Y, Trulock EP, et al. Cardiac and pulmonary replacement: single or bilateral lung transplantation for emphysema? J Thorac Cardiovasc Surg 1996;112:1485-1495.
44. Bavaria JE, Kotloff R, Palevsky H, et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1997;113:520-528.
45. Starnes VA, Barr ML, Cohen RG, et al. Living-donor lobar lung transplantation experience: intermediate results. J Thorac Cardiovasc Surg 1996;112:1284-1291.
46. Binns OAR, DeLima NF, Buchanan SA, et al. Use of oversized mature pulmonary lower lobe grafts result in superior pulmonary function. Ann Thorac Surg 1997;64:307-312.
47. Reichenspurner H, Girgis RE, Robbins RC, et al. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1996;62:1467-1473.
48. D'Armini AM, Lemasters JJ, and Egan TM. Studies of rat lung viability and adenine nucleotide metabolism after death. Ann Thorac Surg 1996;62:1448-1453.
49. Van Raemdonck DEM, Jannis NCP, Rega FRL, et al. Extended preservation of ischemic pulmonary graft by postmortem alveolar expansion. Ann Thorac Surg 1997;64:801-808.
50. Murakami S, Bacha EA, Herve P, et al. Prevention of reperfusion injury by inhaled nitric oxide in lungs harvested from non-heart-beating donors. Ann Thorac Surg 1996;62:1632-1638.
51. Kuang J-Q, Lee A, Giaid A, et al. Successful retrieval and function of lungs from non-heart-beating donors. Surgical Forum, American College of Surgeons 1997;XLVII:317-321.
52. Van Dam J. Endosonographic evaluation of the patient with esophageal cancer. Chest 1997;112:184S-190S.
53. Krasna MJ. Minimally invasive staging for esophageal cancer. Chest 1997;112:191S-194S.
54. Block MI, Patterson GA, Sundaresan RS, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-777.
55. Luketich JD, Schauer PR, Meltzer CC, et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997;64:765-769.
56. Jones DR, Detterbeck FC, Egan TE, et al. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997;64:185-192.
57. Urba S, Orringer M, Turrisi A, et al. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: updated analysis. Proc Am Soc Clin Oncol 1997;16:277.
58. Ellis FH Jr, Heatley GJ, Krasna MJ, et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 1997;113:836-848.
59. Peters JH, and DeMeester TR. Indications, benefits and outcome of laparoscopic Nissen fundoplication. Dig Dis Sci 1996;14:169-179.
60. DeMeester TR. Preoperative assessment and operative management of gastroesophageal reflux: laparoscopic fundoplication. ACS Postgraduate Course, General Thoracic Surgery 1997;8:38-40.
61. Pearson FG. Preoperative assessment and operative management of gastroesophageal reflux: open fundoplication. ACS Postgraduate Course, General Thoracic Surgery 1997;8:41-42.
62. Graham AJ, Finley RJ, Worsley DF, et al. Laparoscopic esophageal myotomy and anterior partial fundoplication for the treatment of achalasia. Ann Thorac Surg 1997;64:785-789.